Zobrazeno 1 - 10
of 30
pro vyhledávání: '"Stephen C. Benson"'
Autor:
Fred H. Wilt, Stephen C. Benson
Publikováno v:
Calcification in Biological Systems
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9d31f82c1275477e1c20b5a977a2001a
https://doi.org/10.1201/9781003068396-9
https://doi.org/10.1201/9781003068396-9
Publikováno v:
Journal of Hypertension. 26:973-980
BACKGROUND Few studies have directly compared the effects of different angiotensin receptor blockers (ARBs) on mechanisms involved in the pathogenesis of cardiovascular disease. METHODS We studied the ability of different ARBs to inhibit the prolifer
Autor:
Theodore W. Kurtz, Cassia S. Mizuno, Prashant V. Desai, Stephen C. Benson, Akshay Patny, Christopher I. Ho, Amar G. Chittiboyina, Meenakshi S. Venkatraman, Mitchell A. Avery, Harrihar A. Pershadsingh
Publikováno v:
Journal of Medicinal Chemistry. 49:4072-4084
A series of novel derivatives of potent antioxidant vitamin, alpha-lipoic acid, and related analogues were designed, synthesized, and evaluated for their PPARgamma agonist activities. Compounds 9a and the water soluble analogue11e were found to be po
Autor:
Paula M. Sweet, Stephen C. Benson, Melvin A. Sarayba, Kathryn Osann, Anup J. Patel, Roy S. Chuck, Norman H. Liu, Harrihar A. Pershadsingh, Amar G. Chittiboyina, Li Li, Tulaya Tungsiripat
Publikováno v:
Experimental Eye Research. 80:435-442
Purpose . To determine the efficacy of the peroxisome proliferator-activated receptor γ agonist, pioglitazone, in inhibiting corneal neovascularization. Methods . Twenty-six adult male Sprague-Dawley rats were randomly divided into three groups. Eac
Publikováno v:
American Journal of Hypertension. 10:440-446
Thiazolidinediones, insulin-sensitizing agents that lower insulin and lipid levels in insulin-resistant states, block agonist-induced Ca2+ entry into vascular smooth muscle (VSM) cells in vitro and lower blood pressure in animals and humans in vivo.
Autor:
Fred H, Wilt, Stephen C, Benson
Publikováno v:
Methods in cell biology. 74
Autor:
Harrihar A. Pershadsingh, Meenakshi S. Venkatraman, Amar G. Chittiboyina, Stephen C. Benson, Charles N. Ellis, Josef G. Meingassner, Theodore W. Kurtz, Christopher I. Ho, James Varani, Mitchell A. Avery
Publikováno v:
Archives of Dermatological Research. 296
Novel thiazolidinedione derivatives of the potent antioxidant, alpha-lipoic (thioctic, 1,2-dithiolane) acid, were prepared. The prototype N-(2-[4-[2,4-dioxo(1,3-thiazolidin-5-yl)methyl]phenoxy]ethyl)-5-(1,2-dithiolan-3-yl)- N-methylpentanamide (desig
Autor:
Mitchell A. Avery, Prashant V. Desai, Jiaming Wang, N. Qi, Amar G. Chittiboyina, Stephen C. Benson, Christopher I. Ho, Michal Pravenec, Harrihar A. Pershadsingh, Theodore W. Kurtz
Publikováno v:
Hypertension (Dallas, Tex. : 1979). 43(5)
The metabolic syndrome is a common precursor of cardiovascular disease and type 2 diabetes that is characterized by the clustering of insulin resistance, dyslipidemia, and increased blood pressure. In humans, mutations in the peroxisome proliferator-
Autor:
Mitchell A. Avery, Narasimharao Bhagavathula, Amar G. Chittiboyina, Theodore W. Kurtz, Harrihar A. Pershadsingh, Kamalakar C. Nerusu, Christopher I. Ho, Stephen C. Benson, Charles N. Ellis, Ashish Lal, James Varani
Publikováno v:
The Journal of investigative dermatology. 122(1)
This study was undertaken to evaluate the effects of thiazolidinediones (TZD) on keratinocyte proliferation, motility, and matrix metalloproteinase (MMP) production. Rosiglitazone (a potent TZD) inhibited both proliferation and motility as well as el
Autor:
Stephen C. Benson, Fred H. Wilt
Publisher Summary The chapter covers the interaction between mesenchyme cells and other cell types, primarily studied by transplantation of micromeres or mesenchyme cells. The general approach used for the isolation and culture of micromeres is to di
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::dda164e6bd1db20ceb0cf3ee5141d9e3
https://doi.org/10.1016/s0091-679x(04)74012-1
https://doi.org/10.1016/s0091-679x(04)74012-1